<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="podbean/3.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>AJP - Heart and Circulatory Physiology</title>
	<atom:link href="http://ajpheart.podbean.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://ajpheart.podbean.com</link>
	<description>Commentary and discussion on featured articles in AJP - Heart and Circulatory Physiology</description>
	<pubDate>Wed, 02 May 2012 15:32:42 +0000</pubDate>
	<generator>http://podbean.com/?v=3.2</generator>
	<language>en</language>
		<!-- podcast_generator="Podbean Engine/5.0" -->
		<category>Science &#038; Medicine</category>
		<ttl>1440</ttl>
		<itunes:keywords>heart,circulatory,physiology</itunes:keywords>
		<itunes:subtitle>Commentary and discussion focusing on featured articles from the American Journal of Physiology - Heart and Circulatory Physiology.		</itunes:subtitle>
		<itunes:summary>New podcast weblog</itunes:summary>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:category text="Science &amp; Medicine"/>
		<itunes:owner>
			<itunes:name>American Physiological Society</itunes:name>
			<itunes:email>mgentry@the-aps.org</itunes:email>
		</itunes:owner>
		<itunes:block>No</itunes:block>
		<itunes:explicit>No</itunes:explicit>
		<itunes:image href="http://media25.podbean.com/s25/363190/itunes_heart_logo.jpg" />
		<image>
			<url>http://media25.podbean.com/s25/363190/itunes_heart_logo.jpg</url>
			<title>AJP - Heart and Circulatory Physiology</title>
			<link>http://ajpheart.podbean.com</link>
			<width>144</width>
			<height>144</height>
		</image>
			<item>
		<title>Neuregulin1/ErbB4 Signaling and Cardiomyocyte Proliferation</title>
		<link>http://ajpheart.podbean.com/2012/05/02/neuregulin1erbb4-signaling-and-cardiomyocyte-proliferation/</link>
		<comments>http://ajpheart.podbean.com/2012/05/02/neuregulin1erbb4-signaling-and-cardiomyocyte-proliferation/#comments</comments>
		<pubDate>Wed, 02 May 2012 15:32:42 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/05/02/neuregulin1erbb4-signaling-and-cardiomyocyte-proliferation/</guid>
		<description><![CDATA[How is cardiac neuregulin signaling involved after herceptin treatment of breast cancer patients? Our latest podcast explores the new Review article by Wadugu et al, which focuses on neuregulin signaling in the heart and dissects early observations that up to 30% of patients treated with herceptin for breast cancer displayed heart failure as a side-effect, [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">How is cardiac neuregulin signaling involved after herceptin treatment of breast cancer patients? Our latest podcast explores the new Review article by Wadugu et al, which focuses on neuregulin signaling in the heart and dissects early observations that up to 30% of patients treated with herceptin for breast cancer displayed heart failure as a side-effect, likely by inhibiting neuregulin signaling. Cardiomyocyte proliferation is just one of many events triggered by neuregulin activation in heart cells, thereby opening a safe, paracrine possibility to stimulate myocyte proliferation in experimental and clinical heart failure studies. Listen as Associate Editor Leon de Windt talks with senior author Bernhard Kuhn (Children&#8217;s Hospital Boston/Harvard Medical School) and leading expert Douglas Sawyer (Vanderbilt University) about stem cell treatments, clinical trials, and much more. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Brian Wadugu and Bernhard Kuhn.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00063.2012"> The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print March 16, 2012, doi: 10.1152/ajpheart.00063.2012.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/05/02/neuregulin1erbb4-signaling-and-cardiomyocyte-proliferation/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/byiv9r/AJPHeartPodcast_5_2_12mp3.mp3" length="9582524" type="audio/mpeg"/>
				<itunes:subtitle>How is cardiac neuregulin signaling involved after herceptin treatment of breast cancer patients? Our latest podcast explores the new Review article by Wadugu et al, ...</itunes:subtitle>
		<itunes:summary>How is cardiac neuregulin signaling involved after herceptin treatment of breast cancer patients? Our latest podcast explores the new Review article by Wadugu et al, which focuses on neuregulin signaling in the heart and dissects early observations that up to 30% of patients treated with herceptin for breast cancer displayed heart failure as a side-effect, likely by inhibiting neuregulin signaling. Cardiomyocyte proliferation is just one of many events triggered by neuregulin activation in heart cells, thereby opening a safe, paracrine possibility to stimulate myocyte proliferation in experimental and clinical heart failure studies. Listen as Associate Editor Leon de Windt talks with senior author Bernhard Kuhn (Children's Hospital Boston/Harvard Medical School) and leading expert Douglas Sawyer (Vanderbilt University) about stem cell treatments, clinical trials, and much more. 
Brian Wadugu and Bernhard Kuhn. The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation Am J Physiol Heart Circ Physiol, published ahead of print March 16, 2012, doi: 10.1152/ajpheart.00063.2012.</itunes:summary>
		<itunes:image href="http://ajpheart.podbean.com/mf/web/kkxbu5/aps_logo.jpg" />
		<itunes:keywords>cardiac repair, cardiac regeneration, cardiomyocyte proliferation, neuregulin,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:58</itunes:duration>
	</item>
		<item>
		<title>O-GlcNAc Signaling During Hypertrophy</title>
		<link>http://ajpheart.podbean.com/2012/04/24/o-glcnac-signaling-during-hypertrophy/</link>
		<comments>http://ajpheart.podbean.com/2012/04/24/o-glcnac-signaling-during-hypertrophy/#comments</comments>
		<pubDate>Tue, 24 Apr 2012 14:37:39 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/04/24/o-glcnac-signaling-during-hypertrophy/</guid>
		<description><![CDATA[Does protein glycosylation drive cardiac hypertrophy? In our latest podcast, Editor in Chief William Stanley talks with senior author Steven P. Jones (University of Louisville) and leading expert John Chatham (University of Alabama at Birmingham) to discuss the work by Facundo et al that explores the role of O-GlcNAc in pathological cardiac hypertrophy through NFAT [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">Does protein glycosylation drive cardiac hypertrophy? In our latest podcast, Editor in Chief William Stanley talks with senior author Steven P. Jones (University of Louisville) and leading expert John Chatham (University of Alabama at Birmingham) to discuss the work by Facundo et al that explores the role of O-GlcNAc in pathological cardiac hypertrophy through NFAT modification. Listen as they discuss the complexities and importance of O-GlcNAc signaling, and explore the methodological challenges in assessing protein O-GlcNAcylation. Is there a role in heart failure or diabetic cardiomyopathy? Listen in and find out. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Heberty T. Facundo, Robert E. Brainard, Lewis J Watson, Gladys A. Ngoh, Tariq Hamid, Sumanth D. Prabhu, and Steven P. Jones</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00775.2011"> O-GlcNAc Signaling is Essential for NFAT-Mediated Transcriptional Reprogramming During Cardiomyocyte Hypertrophy </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print March 9, 2012, doi: 10.1152/ajpheart.00775.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/04/24/o-glcnac-signaling-during-hypertrophy/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/n7jt5a/AJPHeartPodcast_4_24_12mp3.mp3" length="9644156" type="audio/mpeg"/>
				<itunes:subtitle>Does protein glycosylation drive cardiac hypertrophy? In our latest podcast, Editor in Chief William Stanley talks with senior author Steven P. Jones (University of Louisville) ...</itunes:subtitle>
		<itunes:summary>Does protein glycosylation drive cardiac hypertrophy? In our latest podcast, Editor in Chief William Stanley talks with senior author Steven P. Jones (University of Louisville) and leading expert John Chatham (University of Alabama at Birmingham) to discuss the work by Facundo et al that explores the role of O-GlcNAc in pathological cardiac hypertrophy through NFAT modification. Listen as they discuss the complexities and importance of O-GlcNAc signaling, and explore the methodological challenges in assessing protein O-GlcNAcylation. Is there a role in heart failure or diabetic cardiomyopathy? Listen in and find out. 
Heberty T. Facundo, Robert E. Brainard, Lewis J Watson, Gladys A. Ngoh, Tariq Hamid, Sumanth D. Prabhu, and Steven P. Jones O-GlcNAc Signaling is Essential for NFAT-Mediated Transcriptional Reprogramming During Cardiomyocyte Hypertrophy Am J Physiol Heart Circ Physiol, published ahead of print March 9, 2012, doi: 10.1152/ajpheart.00775.2011.</itunes:summary>
		<itunes:image href="http://ajpheart.podbean.com/mf/web/kkxbu5/aps_logo.jpg" />
		<itunes:keywords>hexosamine biosynthetic pathway, metabolism, cardiac hypertrophy, o-glcnac,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:10:02</itunes:duration>
	</item>
		<item>
		<title>Mitochondrial Adaptations and Myocardial Energetics</title>
		<link>http://ajpheart.podbean.com/2012/04/13/mitochondrial-adaptations-and-myocardial-energetics/</link>
		<comments>http://ajpheart.podbean.com/2012/04/13/mitochondrial-adaptations-and-myocardial-energetics/#comments</comments>
		<pubDate>Fri, 13 Apr 2012 17:40:09 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/04/13/mitochondrial-adaptations-and-myocardial-energetics/</guid>
		<description><![CDATA[The protective effect of ischemic preconditioning lasts for only a few hours, then reappears about a day later in what is termed the Second Window of Protection (SWOP). In this podcast Editor in Chief William Stanley interviews senior author Edward McFalls (VA Medical Center, University of Minnesota) and leading expert Nazareno Paolocci (Johns Hopkins University) [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">The protective effect of ischemic preconditioning lasts for only a few hours, then reappears about a day later in what is termed the Second Window of Protection (SWOP). In this podcast Editor in Chief William Stanley interviews senior author Edward McFalls (VA Medical Center, University of Minnesota) and leading expert Nazareno Paolocci (Johns Hopkins University) about the work by Cabrera et al, which brings together an elegant animal model, cutting-edge proteomics technology, and clinical cardiologist and cardiovascular physiologist to uncover the role of the mitochondria and energetics in mediating SWOP. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Jesus A Cabrera, Elizabeth A Ziemba, Robert Colbert, Lorraine Anderson, Willem Sluiter, Dirk J. Duncker, Tammy A Butterick, Joseph Sikora, Herbert B Ward, Rosemary F Kelly, and Edward O McFalls.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00372.2011"> Altered Expression of Mitochondrial Electron Transport Proteins and Improved Myocardial Energetic State During Late Ischemic Preconditioning </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print March 2, 2012, doi: 10.1152/ajpheart.00372.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/04/13/mitochondrial-adaptations-and-myocardial-energetics/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/tzmzrj/AJPHeartPodcast_4_13_12mp3.mp3" length="8734652" type="audio/mpeg"/>
				<itunes:subtitle>The protective effect of ischemic preconditioning lasts for only a few hours, then reappears about a day later in what is termed the Second Window ...</itunes:subtitle>
		<itunes:summary>The protective effect of ischemic preconditioning lasts for only a few hours, then reappears about a day later in what is termed the Second Window of Protection (SWOP). In this podcast Editor in Chief William Stanley interviews senior author Edward McFalls (VA Medical Center, University of Minnesota) and leading expert Nazareno Paolocci (Johns Hopkins University) about the work by Cabrera et al, which brings together an elegant animal model, cutting-edge proteomics technology, and clinical cardiologist and cardiovascular physiologist to uncover the role of the mitochondria and energetics in mediating SWOP. 
Jesus A Cabrera, Elizabeth A Ziemba, Robert Colbert, Lorraine Anderson, Willem Sluiter, Dirk J. Duncker, Tammy A Butterick, Joseph Sikora, Herbert B Ward, Rosemary F Kelly, and Edward O McFalls. Altered Expression of Mitochondrial Electron Transport Proteins and Improved Myocardial Energetic State During Late Ischemic Preconditioning Am J Physiol Heart Circ Physiol, published ahead of print March 2, 2012, doi: 10.1152/ajpheart.00372.2011.</itunes:summary>
				<itunes:keywords>atp, mitochondrial proteomics, second window of protection,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:05</itunes:duration>
	</item>
		<item>
		<title>Photoplethysmography with Valsalva Maneuver Reflects Filling Pressure</title>
		<link>http://ajpheart.podbean.com/2012/04/12/photoplethysmography-with-valsalva-maneuver-reflects-filling-pressure/</link>
		<comments>http://ajpheart.podbean.com/2012/04/12/photoplethysmography-with-valsalva-maneuver-reflects-filling-pressure/#comments</comments>
		<pubDate>Thu, 12 Apr 2012 13:45:43 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/04/12/photoplethysmography-with-valsalva-maneuver-reflects-filling-pressure/</guid>
		<description><![CDATA[What do Valsalva, the 17th century Italian physician, and smartphones have in common? Listen to our latest intriguing podcast which explores how the Valsalva Maneuver, when paired with finger photoplethysmography using a simple pulse oximetry probe, may provide cardiologists with an alternative to cardiac catheterization for heart failure patients. Associate Editor Ajay Shah interviews lead [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">What do Valsalva, the 17th century Italian physician, and smartphones have in common? Listen to our latest intriguing podcast which explores how the Valsalva Maneuver, when paired with finger photoplethysmography using a simple pulse oximetry probe, may provide cardiologists with an alternative to cardiac catheterization for heart failure patients. Associate Editor Ajay Shah interviews lead author Harry Silber (Johns Hopkins University) and expert Charles Chung (University of Arizona) about the work by Silber and colleagues, which knits together classical cardiovascular physiology, clinical cardiology, and inventive uses of existing technologies to provide insights into the left ventricular filling pressure of heart failure patients. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Harry A. Silber, Jeffrey C. Trost, Peter V. Johnston, W. Lowell Maughan, Nae-Yuh Wang, Edward K. Kasper, Thomas R. Aversano, and David E. Bush.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00609.2011"> Finger Photoplethysmography During the Valsalva Maneuver Reflects Left Ventricular Filling Pressure </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print March 2, 2012, doi: 10.1152/ajpheart.00609.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/04/12/photoplethysmography-with-valsalva-maneuver-reflects-filling-pressure/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/xncdtf/AJPHeartPodcast_4_12_12mp3.mp3" length="9704635" type="audio/mpeg"/>
				<itunes:subtitle>What do Valsalva, the 17th century Italian physician, and smartphones have in common? Listen to our latest intriguing podcast which explores how the Valsalva Maneuver, ...</itunes:subtitle>
		<itunes:summary>What do Valsalva, the 17th century Italian physician, and smartphones have in common? Listen to our latest intriguing podcast which explores how the Valsalva Maneuver, when paired with finger photoplethysmography using a simple pulse oximetry probe, may provide cardiologists with an alternative to cardiac catheterization for heart failure patients. Associate Editor Ajay Shah interviews lead author Harry Silber (Johns Hopkins University) and expert Charles Chung (University of Arizona) about the work by Silber and colleagues, which knits together classical cardiovascular physiology, clinical cardiology, and inventive uses of existing technologies to provide insights into the left ventricular filling pressure of heart failure patients. 
Harry A. Silber, Jeffrey C. Trost, Peter V. Johnston, W. Lowell Maughan, Nae-Yuh Wang, Edward K. Kasper, Thomas R. Aversano, and David E. Bush. Finger Photoplethysmography During the Valsalva Maneuver Reflects Left Ventricular Filling Pressure Am J Physiol Heart Circ Physiol, published ahead of print March 2, 2012, doi: 10.1152/ajpheart.00609.2011.</itunes:summary>
				<itunes:keywords>left ventricular end-diastolic pressure, heart failure, pulse amplitude ratio,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:10:06</itunes:duration>
	</item>
		<item>
		<title>Hemin toxicity and autophagy</title>
		<link>http://ajpheart.podbean.com/2012/04/03/hemin-toxicity-and-autophagy/</link>
		<comments>http://ajpheart.podbean.com/2012/04/03/hemin-toxicity-and-autophagy/#comments</comments>
		<pubDate>Tue, 03 Apr 2012 17:55:17 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/04/03/hemin-toxicity-and-autophagy/</guid>
		<description><![CDATA[We know that hemin toxicity effects vascular endothelial cells, which may contribute to cardiovascular diseases. But what is the underlying molecular mechanism? In our newest podcast, Associate Editor Christine des Rosiers interviews senior author Victor Darley-Usmar (University of Alabama at Birmingham) and leading expert Neil Hogg (Medical College of Wisconsin) about the connections between lipid [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">We know that hemin toxicity effects vascular endothelial cells, which may contribute to cardiovascular diseases. But what is the underlying molecular mechanism? In our newest podcast, Associate Editor Christine des Rosiers interviews senior author Victor Darley-Usmar (University of Alabama at Birmingham) and leading expert Neil Hogg (Medical College of Wisconsin) about the connections between lipid peroxidation in cells and its damaging effects on mitochondrial function, and the role autophagy may play in protecting those mitochondria from damage. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Ashlee N. Higdon, Gloria A. Benavides, Balu K. Chacko, Xiaosen Ouyang, Michelle S. Johnson, Aimee Landar, Jianhua Zhang, Victor M. Darley-Usmar.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00584.2011"> Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy </a><em>Am J Physiol Heart Circ Physiol</em>, published online April 1, 2012, doi: 10.1152/ajpheart.00584.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/04/03/hemin-toxicity-and-autophagy/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/ej3dpt/AJPHeartPodcast_4_3_12mp3.mp3" length="9563507" type="audio/mpeg"/>
				<itunes:subtitle>We know that hemin toxicity effects vascular endothelial cells, which may contribute to cardiovascular diseases. But what is the underlying molecular mechanism? In our newest ...</itunes:subtitle>
		<itunes:summary>We know that hemin toxicity effects vascular endothelial cells, which may contribute to cardiovascular diseases. But what is the underlying molecular mechanism? In our newest podcast, Associate Editor Christine des Rosiers interviews senior author Victor Darley-Usmar (University of Alabama at Birmingham) and leading expert Neil Hogg (Medical College of Wisconsin) about the connections between lipid peroxidation in cells and its damaging effects on mitochondrial function, and the role autophagy may play in protecting those mitochondria from damage. 
Ashlee N. Higdon, Gloria A. Benavides, Balu K. Chacko, Xiaosen Ouyang, Michelle S. Johnson, Aimee Landar, Jianhua Zhang, Victor M. Darley-Usmar. Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy Am J Physiol Heart Circ Physiol, published online April 1, 2012, doi: 10.1152/ajpheart.00584.2011.</itunes:summary>
				<itunes:keywords>mitophagy, mitochondrial function, reserve capacity, extracellular flux,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:57</itunes:duration>
	</item>
		<item>
		<title>Nerve induced EC Ca2+ signals oppose vasoconstriction</title>
		<link>http://ajpheart.podbean.com/2012/03/14/nerve-induced-ec-ca2-signals-oppose-vasoconstriction/</link>
		<comments>http://ajpheart.podbean.com/2012/03/14/nerve-induced-ec-ca2-signals-oppose-vasoconstriction/#comments</comments>
		<pubDate>Wed, 14 Mar 2012 15:54:54 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/03/14/nerve-induced-ec-ca2-signals-oppose-vasoconstriction/</guid>
		<description><![CDATA[Our latest podcast takes us into the realm of calcium pulsars. Associate Editor Nancy Kanagy talks with senior author Mark Nelson (University of Vermont) and leading expert Michael Hill (University of Missouri) about how the work of Nausch et al challenges the traditional view that the sympathetic nervous system regulates vascular tone independent of the [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">Our latest podcast takes us into the realm of calcium pulsars. Associate Editor Nancy Kanagy talks with senior author Mark Nelson (University of Vermont) and leading expert Michael Hill (University of Missouri) about how the work of Nausch et al challenges the traditional view that the sympathetic nervous system regulates vascular tone independent of the endothelium. This work by Nelson and colleagues shows that the endothelium is dynamically engaged during neurovascular coupling through transcellular negative feedback which limits vasoconstriction. Listen as we explore how the vascular smooth muscle communicates with the endothelium, and the potential significance of this EDH mechanism to oppose sympathetically-mediated constriction.</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Lydia W. M. Nausch, Adrian D. Bonev, Thomas J. Heppner, Yvonne Tallini, Michael I. Kotlikoff, Mark T. Nelson.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00773.2011"> Sympathetic nerve stimulation induces local endothelial Ca2+ signals to oppose vasoconstriction of mouse mesenteric arteries </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print December 2, 2011, doi:10.1152/ajpheart.00773.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/03/14/nerve-induced-ec-ca2-signals-oppose-vasoconstriction/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/jfueh5/AJPHeartPodcast_3_14_12mp3.mp3" length="9671806" type="audio/mpeg"/>
				<itunes:subtitle>Our latest podcast takes us into the realm of calcium pulsars. Associate Editor Nancy Kanagy talks with senior author Mark Nelson (University of Vermont) and ...</itunes:subtitle>
		<itunes:summary>Our latest podcast takes us into the realm of calcium pulsars. Associate Editor Nancy Kanagy talks with senior author Mark Nelson (University of Vermont) and leading expert Michael Hill (University of Missouri) about how the work of Nausch et al challenges the traditional view that the sympathetic nervous system regulates vascular tone independent of the endothelium. This work by Nelson and colleagues shows that the endothelium is dynamically engaged during neurovascular coupling through transcellular negative feedback which limits vasoconstriction. Listen as we explore how the vascular smooth muscle communicates with the endothelium, and the potential significance of this EDH mechanism to oppose sympathetically-mediated constriction.
Lydia W. M. Nausch, Adrian D. Bonev, Thomas J. Heppner, Yvonne Tallini, Michael I. Kotlikoff, Mark T. Nelson. Sympathetic nerve stimulation induces local endothelial Ca2+ signals to oppose vasoconstriction of mouse mesenteric arteries Am J Physiol Heart Circ Physiol, published ahead of print December 2, 2011, doi:10.1152/ajpheart.00773.2011.</itunes:summary>
				<itunes:keywords>calcium pulsars, myoendothelial junction, vascular smooth muscle, ip3 receptors,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:10:04</itunes:duration>
	</item>
		<item>
		<title>In pursuit of scientific excellence - sex matters</title>
		<link>http://ajpheart.podbean.com/2012/02/28/in-pursuit-of-scientific-excellence-sex-matters/</link>
		<comments>http://ajpheart.podbean.com/2012/02/28/in-pursuit-of-scientific-excellence-sex-matters/#comments</comments>
		<pubDate>Tue, 28 Feb 2012 15:46:50 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/02/28/in-pursuit-of-scientific-excellence-sex-matters/</guid>
		<description><![CDATA[Sex and gender matter in physiology, but are frequently ignored in scientific publications. In our latest podcast, Editor in Chief William Stanley has a lively conversation with leading experts Virginia Miller (Mayo Clinic) and Jane Reckelhoff (University of Mississippi) about the importance of sex and gender differences in physiology research and publications. Clear sex differences [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">Sex and gender matter in physiology, but are frequently ignored in scientific publications. In our latest podcast, Editor in Chief William Stanley has a lively conversation with leading experts Virginia Miller (Mayo Clinic) and Jane Reckelhoff (University of Mississippi) about the importance of sex and gender differences in physiology research and publications. Clear sex differences are apparent at the molecular, cellular and whole organ levels, prompting a new editorial policy for the American Physiological Society publications which requires reporting of the sex and/or gender of animals and humans, as well as all derived materials. Learn about how to approach this important issue in your work, and the surprising effects of sex on physiology from the molecular level on up.</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Virginia M. Miller.</strong> <a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00073.2012">In pursuit of scientific excellence - sex matters </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print February 10, 2012, doi: 10.1152/ajpheart.00073.2012.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/02/28/in-pursuit-of-scientific-excellence-sex-matters/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/ej7wfx/AJPHeartPodcast_2_28_12mp3.mp3" length="9619401" type="audio/mpeg"/>
				<itunes:subtitle>Sex and gender matter in physiology, but are frequently ignored in scientific publications. In our latest podcast, Editor in Chief William Stanley has a lively ...</itunes:subtitle>
		<itunes:summary>Sex and gender matter in physiology, but are frequently ignored in scientific publications. In our latest podcast, Editor in Chief William Stanley has a lively conversation with leading experts Virginia Miller (Mayo Clinic) and Jane Reckelhoff (University of Mississippi) about the importance of sex and gender differences in physiology research and publications. Clear sex differences are apparent at the molecular, cellular and whole organ levels, prompting a new editorial policy for the American Physiological Society publications which requires reporting of the sex and/or gender of animals and humans, as well as all derived materials. Learn about how to approach this important issue in your work, and the surprising effects of sex on physiology from the molecular level on up.
Virginia M. Miller. In pursuit of scientific excellence - sex matters Am J Physiol Heart Circ Physiol, published ahead of print February 10, 2012, doi: 10.1152/ajpheart.00073.2012.</itunes:summary>
				<itunes:keywords>sex differences, gender differences, physiology,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:10:01</itunes:duration>
	</item>
		<item>
		<title>Fructose diet-induced cardiomyocyte Ca2+ cycling abnormality</title>
		<link>http://ajpheart.podbean.com/2012/02/09/fructose-diet-induced-cardiomyocyte-ca2-cycling-abnormality/</link>
		<comments>http://ajpheart.podbean.com/2012/02/09/fructose-diet-induced-cardiomyocyte-ca2-cycling-abnormality/#comments</comments>
		<pubDate>Thu, 09 Feb 2012 17:36:49 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/02/09/fructose-diet-induced-cardiomyocyte-ca2-cycling-abnormality/</guid>
		<description><![CDATA[In our latest podcast we explore the cardiac-specific effects of a high fructose diet. An inventive new study by Mellor et al investigates excitation contraction coupling changes in myocytes isolated from an experimental mouse model. These studies reveal, upon high fructose feeding, marked alterations in myocyte Ca2+ handling, but with maintained contractile function. Associate Editor [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">In our latest podcast we explore the cardiac-specific effects of a high fructose diet. An inventive new study by Mellor et al investigates excitation contraction coupling changes in myocytes isolated from an experimental mouse model. These studies reveal, upon high fructose feeding, marked alterations in myocyte Ca2+ handling, but with maintained contractile function. Associate Editor Meredith Bond and leading expert Susan Howlett (Dalhousie University) interview senior author Lea Delbridge (University of Melbourne) about her exciting new work on diabetic cardiomyopathy.</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Kimberley M Mellor, Igor R Wendt, Rebecca H Ritchie, and Lea M.D. Delbridge.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00797.2011"> Fructose diet treatment in mice induces fundamental disturbance of cardiomyocyte Ca2+ handling and myofilament responsiveness </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print December 23, 2011, doi:10.1152/ajpheart.00797.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/02/09/fructose-diet-induced-cardiomyocyte-ca2-cycling-abnormality/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/xscuwt/AJPHeartPodcast_2_9_12mp3.mp3" length="8990399" type="audio/mpeg"/>
				<itunes:subtitle>In our latest podcast we explore the cardiac-specific effects of a high fructose diet. An inventive new study by Mellor et al investigates excitation contraction ...</itunes:subtitle>
		<itunes:summary>In our latest podcast we explore the cardiac-specific effects of a high fructose diet. An inventive new study by Mellor et al investigates excitation contraction coupling changes in myocytes isolated from an experimental mouse model. These studies reveal, upon high fructose feeding, marked alterations in myocyte Ca2+ handling, but with maintained contractile function. Associate Editor Meredith Bond and leading expert Susan Howlett (Dalhousie University) interview senior author Lea Delbridge (University of Melbourne) about her exciting new work on diabetic cardiomyopathy.
Kimberley M Mellor, Igor R Wendt, Rebecca H Ritchie, and Lea M.D. Delbridge. Fructose diet treatment in mice induces fundamental disturbance of cardiomyocyte Ca2+ handling and myofilament responsiveness Am J Physiol Heart Circ Physiol, published ahead of print December 23, 2011, doi:10.1152/ajpheart.00797.2011.</itunes:summary>
				<itunes:keywords>high fructose diet, diabetic cardiomyopathy, myocardial insulin resistance,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:21</itunes:duration>
	</item>
		<item>
		<title>Molecular mechanisms linking salt to hypertension</title>
		<link>http://ajpheart.podbean.com/2012/02/06/molecular-mechanisms-linking-salt-to-hypertension/</link>
		<comments>http://ajpheart.podbean.com/2012/02/06/molecular-mechanisms-linking-salt-to-hypertension/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 19:15:48 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/02/06/molecular-mechanisms-linking-salt-to-hypertension/</guid>
		<description><![CDATA[It is well known that there is no single cause of hypertension, but many of the factors that contribute to hypertension are known. Our latest podcast spotlights an elegant new Review article by Blaustein and colleagues which focuses on the interplay of salt and the secretion and action of endogenous ouabain. Associate Editor Irving Zucker [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">It is well known that there is no single cause of hypertension, but many of the factors that contribute to hypertension are known. Our latest podcast spotlights an elegant new Review article by Blaustein and colleagues which focuses on the interplay of salt and the secretion and action of endogenous ouabain. Associate Editor Irving Zucker interviews senior author, and fellow Associate Editor, Mordecai Blaustein (University of Maryland), along with leading expert John Osborn (University of Minnesota) about how endogenous ouabain might contribute to salt-sensitive hypertension and plays a central role in the alterations in the central nervous system, kidney and vasculature which contribute to chronic hypertension. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Mordecai P. Blaustein, Frans HH Leenen, Ling Chen, Vera A. Golovina, John M Hamlyn, Thomas L Pallone, James W. Van Huysse, Jin Zhang, Withrow Gil Wier.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00899.2011"> How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print November 4, 2011, doi:10.1152/ajpheart.00899.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/02/06/molecular-mechanisms-linking-salt-to-hypertension/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/ce9vw/AJPHeartPodcast_2_6_12mp3.mp3" length="9528378" type="audio/mpeg"/>
				<itunes:subtitle>It is well known that there is no single cause of hypertension, but many of the factors that contribute to hypertension are known. Our latest ...</itunes:subtitle>
		<itunes:summary>It is well known that there is no single cause of hypertension, but many of the factors that contribute to hypertension are known. Our latest podcast spotlights an elegant new Review article by Blaustein and colleagues which focuses on the interplay of salt and the secretion and action of endogenous ouabain. Associate Editor Irving Zucker interviews senior author, and fellow Associate Editor, Mordecai Blaustein (University of Maryland), along with leading expert John Osborn (University of Minnesota) about how endogenous ouabain might contribute to salt-sensitive hypertension and plays a central role in the alterations in the central nervous system, kidney and vasculature which contribute to chronic hypertension. 
Mordecai P. Blaustein, Frans HH Leenen, Ling Chen, Vera A. Golovina, John M Hamlyn, Thomas L Pallone, James W. Van Huysse, Jin Zhang, Withrow Gil Wier. How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension Am J Physiol Heart Circ Physiol, published ahead of print November 4, 2011, doi:10.1152/ajpheart.00899.2011.</itunes:summary>
				<itunes:keywords>endogenous ouabain, salt-dependent hypertension, ca2+ signaling,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:55</itunes:duration>
	</item>
		<item>
		<title>BH4 and Vascular Function in Women</title>
		<link>http://ajpheart.podbean.com/2012/02/02/bh4-and-vascular-function-in-women/</link>
		<comments>http://ajpheart.podbean.com/2012/02/02/bh4-and-vascular-function-in-women/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 18:04:56 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/02/02/bh4-and-vascular-function-in-women/</guid>
		<description><![CDATA[What&#8217;s the problem with arterial function following menopause? Listen as Editor in Chief William Stanley, senior author Kerrie Moreau (University of Colorado Denver), and leading women’s health expert Virginia Miller (Mayo Clinic) engage in a lively conversation about the latest clinical study by Moreau et al on the role of estrogen and uncoupled nitric oxide [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">What&#8217;s the problem with arterial function following menopause? Listen as Editor in Chief William Stanley, senior author Kerrie Moreau (University of Colorado Denver), and leading women’s health expert Virginia Miller (Mayo Clinic) engage in a lively conversation about the latest clinical study by Moreau et al on the role of estrogen and uncoupled nitric oxide synthase in arterial stiffening in post-menopausal women. Can early intervention with estrogen combat accelerated vascular aging after menopause?</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Kerrie L Moreau, Amie Meditz, Kevin Deane, Wendy M. Kohrt. </strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.01065.2011">Tetrahydrobiopterin Improves Endothelial Function and Decreases Arterial Stiffness in Estrogen-Deficient Postmenopausal Women </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print January 13, 2012, doi:10.1152/ajpheart.01065.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/02/02/bh4-and-vascular-function-in-women/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/zrf8mk/AJPHeartPodcast_2_2_12mp3.mp3" length="9401753" type="audio/mpeg"/>
				<itunes:subtitle>What's the problem with arterial function following menopause? Listen as Editor in Chief William Stanley, senior author Kerrie Moreau (University of Colorado Denver), and leading ...</itunes:subtitle>
		<itunes:summary>What's the problem with arterial function following menopause? Listen as Editor in Chief William Stanley, senior author Kerrie Moreau (University of Colorado Denver), and leading women’s health expert Virginia Miller (Mayo Clinic) engage in a lively conversation about the latest clinical study by Moreau et al on the role of estrogen and uncoupled nitric oxide synthase in arterial stiffening in post-menopausal women. Can early intervention with estrogen combat accelerated vascular aging after menopause?
Kerrie L Moreau, Amie Meditz, Kevin Deane, Wendy M. Kohrt. Tetrahydrobiopterin Improves Endothelial Function and Decreases Arterial Stiffness in Estrogen-Deficient Postmenopausal Women Am J Physiol Heart Circ Physiol, published ahead of print January 13, 2012, doi:10.1152/ajpheart.01065.2011</itunes:summary>
				<itunes:keywords>menopause, arterial stiffening, bh4, estrogen deficiency,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:47</itunes:duration>
	</item>
		<item>
		<title>Obesity and orthopedic trauma</title>
		<link>http://ajpheart.podbean.com/2012/01/18/obesity-and-orthopedic-trauma/</link>
		<comments>http://ajpheart.podbean.com/2012/01/18/obesity-and-orthopedic-trauma/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:00:05 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/01/18/obesity-and-orthopedic-trauma/</guid>
		<description><![CDATA[The obesity epidemic in the United States shows no signs of abating, which is why our latest podcast is particularly insightful. Associate Editor Nancy Kanagy talks with author Lusha Xiang (University of Mississippi) and leading expert Jeff Frisbee (West Virginia University) about the study by Xiang and colleagues, which suggests the mechanism behind the poor [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">The obesity epidemic in the United States shows no signs of abating, which is why our latest podcast is particularly insightful. Associate Editor Nancy Kanagy talks with author Lusha Xiang (University of Mississippi) and leading expert Jeff Frisbee (West Virginia University) about the study by Xiang and colleagues, which suggests the mechanism behind the poor prognosis for obese trauma victims and provides insight into a new therapeutic intervention to improve recovery of obese victims of traumatic injury. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Lusha Xiang, Silu Lu, William Fuller, Arun Aneja, George V Russell, Louis B Jones, and Robert L. Hester.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00439.2011"> Impaired blood pressure recovery to hemorrhage in obese Zucker rats with orthopedic trauma.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print October 14, 2011, doi: 10.1152/ajpheart.00439.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/01/18/obesity-and-orthopedic-trauma/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/gimthu/AJPHeartPodcast_1-18-12mp3.mp3" length="9347509" type="audio/mpeg"/>
				<itunes:subtitle>The obesity epidemic in the United States shows no signs of abating, which is why our latest podcast is particularly insightful. Associate Editor Nancy Kanagy ...</itunes:subtitle>
		<itunes:summary>The obesity epidemic in the United States shows no signs of abating, which is why our latest podcast is particularly insightful. Associate Editor Nancy Kanagy talks with author Lusha Xiang (University of Mississippi) and leading expert Jeff Frisbee (West Virginia University) about the study by Xiang and colleagues, which suggests the mechanism behind the poor prognosis for obese trauma victims and provides insight into a new therapeutic intervention to improve recovery of obese victims of traumatic injury. 
Lusha Xiang, Silu Lu, William Fuller, Arun Aneja, George V Russell, Louis B Jones, and Robert L. Hester. Impaired blood pressure recovery to hemorrhage in obese Zucker rats with orthopedic trauma. Am J Physiol Heart Circ Physiol, published ahead of print October 14, 2011, doi: 10.1152/ajpheart.00439.2011.</itunes:summary>
				<itunes:keywords>orthopedic trauma, hemorrhage, blood pressure, sympathetic activity,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:44</itunes:duration>
	</item>
		<item>
		<title>Muscle oxygen transport and utilization in heart failure</title>
		<link>http://ajpheart.podbean.com/2012/01/11/muscle-oxygen-transport-and-utilization-in-heart-failure/</link>
		<comments>http://ajpheart.podbean.com/2012/01/11/muscle-oxygen-transport-and-utilization-in-heart-failure/#comments</comments>
		<pubDate>Wed, 11 Jan 2012 18:20:16 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/01/11/muscle-oxygen-transport-and-utilization-in-heart-failure/</guid>
		<description><![CDATA[A well-known problem for heart failure patients is the inability, or markedly decreased ability, to exercise. When even low levels of daily activity are impaired, the quality of life for heart failure patients suffers considerably. The mechanisms for exercise intolerance are very complicated and extend far beyond impaired cardiac performance. Listen in as Associate Editor [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">A well-known problem for heart failure patients is the inability, or markedly decreased ability, to exercise. When even low levels of daily activity are impaired, the quality of life for heart failure patients suffers considerably. The mechanisms for exercise intolerance are very complicated and extend far beyond impaired cardiac performance. Listen in as Associate Editor Irving Zucker, senior author David Poole (Kansas State University) and leading expert Peter Wagner (University of California, San Diego) discuss the new Review article by Poole and colleagues, which tackles the mechanisms of muscle dysfunction in heart failure at the oxygen transport and microcirculatory levels. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>David C. Poole, Daniel M. Hirai, Steven W. Copp, and Timothy I. Musch.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00943.2011"> Muscle Oxygen Transport and Utilization in Heart Failure: Implications for Exercise (In)tolerance </a><em>Am J Physiol Heart Circ Physiol</em>, published ahead of print November 18, 2011, doi:10.1152/ajpheart.00943.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/01/11/muscle-oxygen-transport-and-utilization-in-heart-failure/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/vq4kqv/AJPHeartPodcast_1_11_12mp3.mp3" length="9327925" type="audio/mpeg"/>
				<itunes:subtitle>A well-known problem for heart failure patients is the inability, or markedly decreased ability, to exercise. When even low levels of daily activity are impaired, ...</itunes:subtitle>
		<itunes:summary>A well-known problem for heart failure patients is the inability, or markedly decreased ability, to exercise. When even low levels of daily activity are impaired, the quality of life for heart failure patients suffers considerably. The mechanisms for exercise intolerance are very complicated and extend far beyond impaired cardiac performance. Listen in as Associate Editor Irving Zucker, senior author David Poole (Kansas State University) and leading expert Peter Wagner (University of California, San Diego) discuss the new Review article by Poole and colleagues, which tackles the mechanisms of muscle dysfunction in heart failure at the oxygen transport and microcirculatory levels. 
David C. Poole, Daniel M. Hirai, Steven W. Copp, and Timothy I. Musch. Muscle Oxygen Transport and Utilization in Heart Failure: Implications for Exercise (In)tolerance Am J Physiol Heart Circ Physiol, published ahead of print November 18, 2011, doi:10.1152/ajpheart.00943.2011.</itunes:summary>
				<itunes:keywords>congestive heart failure, oxygen uptake kinetics, exercise training,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:42</itunes:duration>
	</item>
		<item>
		<title>Interstitial Volume Modulates the Conduction Velocity- Gap Junction Relationship</title>
		<link>http://ajpheart.podbean.com/2012/01/06/interstitial-volume-modulates-the-conduction-velocity-gap-junction-relationship/</link>
		<comments>http://ajpheart.podbean.com/2012/01/06/interstitial-volume-modulates-the-conduction-velocity-gap-junction-relationship/#comments</comments>
		<pubDate>Fri, 06 Jan 2012 15:26:04 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2012/01/06/interstitial-volume-modulates-the-conduction-velocity-gap-junction-relationship/</guid>
		<description><![CDATA[What are the parameters which modulate conduction under normal and disease conditions in the heart? This age-old debate has pitted two distinct schools of thought against each other—ephaptic conduction vs. gap junctions. Can changes in interstitial volume by pharmacological means dramatically change conduction velocity? In our latest podcast on the article by Veeraraghavan et al, [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">What are the parameters which modulate conduction under normal and disease conditions in the heart? This age-old debate has pitted two distinct schools of thought against each other—ephaptic conduction vs. gap junctions. Can changes in interstitial volume by pharmacological means dramatically change conduction velocity? In our latest podcast on the article by Veeraraghavan et al, Associate Editor Igor Efimov, leading expert Craig Henriquez (Duke University) and senior author Steven Poelzing (University of Utah) wade into the debate.
</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Rengasayee Veeraraghavan, Mohamed E. Salama, and Steven Poelzing.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00868.2011"> Interstitial volume modulates the conduction velocity-gap junction relationship.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print October 21, 2011, doi: 10.1152/ajpheart.00868.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2012/01/06/interstitial-volume-modulates-the-conduction-velocity-gap-junction-relationship/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/j4takr/AJPHeartPodcast_1_6_12mp3.mp3" length="10002993" type="audio/mpeg"/>
				<itunes:subtitle>What are the parameters which modulate conduction under normal and disease conditions in the heart? This age-old debate has pitted two distinct schools of thought ...</itunes:subtitle>
		<itunes:summary>What are the parameters which modulate conduction under normal and disease conditions in the heart? This age-old debate has pitted two distinct schools of thought against each other—ephaptic conduction vs. gap junctions. Can changes in interstitial volume by pharmacological means dramatically change conduction velocity? In our latest podcast on the article by Veeraraghavan et al, Associate Editor Igor Efimov, leading expert Craig Henriquez (Duke University) and senior author Steven Poelzing (University of Utah) wade into the debate.

Rengasayee Veeraraghavan, Mohamed E. Salama, and Steven Poelzing. Interstitial volume modulates the conduction velocity-gap junction relationship. Am J Physiol Heart Circ Physiol, published ahead of print October 21, 2011, doi: 10.1152/ajpheart.00868.2011</itunes:summary>
				<itunes:keywords>cardiac conduction, edema, gap junctions, arrhythmia,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:10:25</itunes:duration>
	</item>
		<item>
		<title>Mitofusin-1 Deficiency in the Heart</title>
		<link>http://ajpheart.podbean.com/2011/12/13/mitofusin-1-deficiency-in-the-heart/</link>
		<comments>http://ajpheart.podbean.com/2011/12/13/mitofusin-1-deficiency-in-the-heart/#comments</comments>
		<pubDate>Tue, 13 Dec 2011 19:01:41 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/12/13/mitofusin-1-deficiency-in-the-heart/</guid>
		<description><![CDATA[Our latest podcast focuses on mitochondrial dynamics, as senior author Ken Walsh (Boston University) and expert Elizabeth “Tish” Murphy (NHLBI) join Consulting Editor Michael Wolin to discuss the recent study by Papanicolau et al, showing surprising effects of cardiac deletion of the key mitochondrial membrane protein mitofusin-1. Listen in as we uncover the unexpected impact [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">Our latest podcast focuses on mitochondrial dynamics, as senior author Ken Walsh (Boston University) and expert Elizabeth “Tish” Murphy (NHLBI) join Consulting Editor Michael Wolin to discuss the recent study by Papanicolau et al, showing surprising effects of cardiac deletion of the key mitochondrial membrane protein mitofusin-1. Listen in as we uncover the unexpected impact of mitofusin-1 and mitofusin-2 on mitochondrial size and resistance to stress.
</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Kyriakos N. Papanicolaou, Gladys A. Ngoh, Errine R Dabkowski, Kelly A O&#8217;Connell, Rogerio F. Ribeiro, William C. Stanley, and Kenneth Walsh.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00833.2011"> Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print October 28, 2011, doi: 10.1152/ajpheart.00833.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/12/13/mitofusin-1-deficiency-in-the-heart/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/i2akc/AJPHeartPodcast_12_13_11mp3.mp3" length="9451584" type="audio/mpeg"/>
				<itunes:subtitle>Our latest podcast focuses on mitochondrial dynamics, as senior author Ken Walsh (Boston University) and expert Elizabeth “Tish” Murphy (NHLBI) join Consulting Editor Michael Wolin ..</itunes:subtitle>
		<itunes:summary>Our latest podcast focuses on mitochondrial dynamics, as senior author Ken Walsh (Boston University) and expert Elizabeth “Tish” Murphy (NHLBI) join Consulting Editor Michael Wolin to discuss the recent study by Papanicolau et al, showing surprising effects of cardiac deletion of the key mitochondrial membrane protein mitofusin-1. Listen in as we uncover the unexpected impact of mitofusin-1 and mitofusin-2 on mitochondrial size and resistance to stress.

Kyriakos N. Papanicolaou, Gladys A. Ngoh, Errine R Dabkowski, Kelly A O'Connell, Rogerio F. Ribeiro, William C. Stanley, and Kenneth Walsh. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am J Physiol Heart Circ Physiol, published ahead of print October 28, 2011, doi: 10.1152/ajpheart.00833.2011</itunes:summary>
				<itunes:keywords>mitochondrial dynamics, gtpase, dynamin, membrane permeability, apoptosis,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>00:09:50</itunes:duration>
	</item>
		<item>
		<title>SIRT3 and cardiac mitochondria</title>
		<link>http://ajpheart.podbean.com/2011/11/17/sirt3-and-cardiac-mitochondria/</link>
		<comments>http://ajpheart.podbean.com/2011/11/17/sirt3-and-cardiac-mitochondria/#comments</comments>
		<pubDate>Thu, 17 Nov 2011 18:41:27 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/11/17/sirt3-and-cardiac-mitochondria/</guid>
		<description><![CDATA[Post-translational modification through acetylation by the NAD+-dependent deacetylase sirtuin-3, or SIRT3, has recently emerged as a key player in regulating mitochondrial function. What is SIRT3 doing in cardiac mitochondria? How does it impact cardiac physiology and pathophysiology? Listen as Editor in Chief William Stanley and Associate Editor Junichi Sadoshima talk with the author Michael Sack [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">Post-translational modification through acetylation by the NAD+-dependent deacetylase sirtuin-3, or SIRT3, has recently emerged as a key player in regulating mitochondrial function. What is SIRT3 doing in cardiac mitochondria? How does it impact cardiac physiology and pathophysiology? Listen as Editor in Chief William Stanley and Associate Editor Junichi Sadoshima talk with the author Michael Sack (National Heart, Lung and Blood Institute, NIH) about his just-published Review article which tackles these very questions. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Michael N. Sack.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00199.2011"> Emerging characterization of the role of SIRT3 mediated mitochondrial protein deacetylation in the heart.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print October 7, 2011, doi:10.1152/ajpheart.00199.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/11/17/sirt3-and-cardiac-mitochondria/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/2imcuf/AJPHeartPodcast_11_17_11mp3.mp3" length="9075046" type="audio/mpeg"/>
				<itunes:subtitle>Post-translational modification through acetylation by the NAD+-dependent deacetylase sirtuin-3, or SIRT3, has recently emerged as a key player in regulating mitochondrial function. What is SIRT3 ...</itunes:subtitle>
		<itunes:summary>Post-translational modification through acetylation by the NAD+-dependent deacetylase sirtuin-3, or SIRT3, has recently emerged as a key player in regulating mitochondrial function. What is SIRT3 doing in cardiac mitochondria? How does it impact cardiac physiology and pathophysiology? Listen as Editor in Chief William Stanley and Associate Editor Junichi Sadoshima talk with the author Michael Sack (National Heart, Lung and Blood Institute, NIH) about his just-published Review article which tackles these very questions. 
Michael N. Sack. Emerging characterization of the role of SIRT3 mediated mitochondrial protein deacetylation in the heart. Am J Physiol Heart Circ Physiol, published ahead of print October 7, 2011, doi:10.1152/ajpheart.00199.2011.</itunes:summary>
				<itunes:keywords>sirt3, mitochondria, cardiac hypertrophy, mnsod, cylcophilin d,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>09:27</itunes:duration>
	</item>
		<item>
		<title>Electrophysiology of hiPSC-derived cardiomyocytes</title>
		<link>http://ajpheart.podbean.com/2011/11/09/electrophysiology-of-hipsc-derived-cardiomyocytes/</link>
		<comments>http://ajpheart.podbean.com/2011/11/09/electrophysiology-of-hipsc-derived-cardiomyocytes/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 14:01:06 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/11/09/electrophysiology-of-hipsc-derived-cardiomyocytes/</guid>
		<description><![CDATA[The discovery of induced pluripotent stem (iPS) cells has allowed researchers to generate human cardiomyocytes from patients. Why is this important? Human iPS cells are useful for studying normal and diseased human cardiomyocytes and for discovering new drug therapies to treat cardiovascular disease. Until now, methods for generating cardiomyocytes from human iPS or ES cells [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">The discovery of induced pluripotent stem (iPS) cells has allowed researchers to generate human cardiomyocytes from patients. Why is this important? Human iPS cells are useful for studying normal and diseased human cardiomyocytes and for discovering new drug therapies to treat cardiovascular disease. Until now, methods for generating cardiomyocytes from human iPS or ES cells were inconsistent and often unreliable. The recent article by Ma et al presents a new method to obtain a large quantity of cultured cardiac myocytes using embryoid body formation and blasticidin selection techniques resulting in more than 98% purity from human iPS cell lines. Associate Editor Junichi Sadoshima talks with authors Craig January (University of Wisconsin – Madison) and Brad Swanson (Cellular Dynamics International), along with leading expert Diego Fraidenraich (University of Medicine and Dentistry, New Jersey), about this groundbreaking research and its many potential applications.</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Junyi Ma, Liang Guo, Steve J Fiene, Blake D Anson, James A Thomson, Timothy J. Kamp, Kyle L Kolaja, Bradley J Swanson, and Craig T. January.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00694.2011"> High Purity Human Induced Pluripotent Stem Cell (hiPSC) Derived Cardiomyocytes: Electrophysiological Properties of Action Potentials and Ionic Currents.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print September 2, 2011, doi:10.1152/ajpheart.00694.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/11/09/electrophysiology-of-hipsc-derived-cardiomyocytes/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/75a7e8/AJPHeartPodcast_11_9_11mp3.mp3" length="9509335" type="audio/mpeg"/>
				<itunes:subtitle>The discovery of induced pluripotent stem (iPS) cells has allowed researchers to generate human cardiomyocytes from patients. Why is this important? Human iPS cells are ...</itunes:subtitle>
		<itunes:summary>The discovery of induced pluripotent stem (iPS) cells has allowed researchers to generate human cardiomyocytes from patients. Why is this important? Human iPS cells are useful for studying normal and diseased human cardiomyocytes and for discovering new drug therapies to treat cardiovascular disease. Until now, methods for generating cardiomyocytes from human iPS or ES cells were inconsistent and often unreliable. The recent article by Ma et al presents a new method to obtain a large quantity of cultured cardiac myocytes using embryoid body formation and blasticidin selection techniques resulting in more than 98% purity from human iPS cell lines. Associate Editor Junichi Sadoshima talks with authors Craig January (University of Wisconsin – Madison) and Brad Swanson (Cellular Dynamics International), along with leading expert Diego Fraidenraich (University of Medicine and Dentistry, New Jersey), about this groundbreaking research and its many potential applications.
Junyi Ma, Liang Guo, Steve J Fiene, Blake D Anson, James A Thomson, Timothy J. Kamp, Kyle L Kolaja, Bradley J Swanson, and Craig T. January. High Purity Human Induced Pluripotent Stem Cell (hiPSC) Derived Cardiomyocytes: Electrophysiological Properties of Action Potentials and Ionic Currents. Am J Physiol Heart Circ Physiol, published ahead of print September 2, 2011, doi:10.1152/ajpheart.00694.2011</itunes:summary>
				<itunes:keywords>human induced pluripotent stem cells, cardiomyocyte, embryoid body formation,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>09:54</itunes:duration>
	</item>
		<item>
		<title>Carotid baroreflex responsiveness is impaired in normotensive African American men</title>
		<link>http://ajpheart.podbean.com/2011/11/03/carotid-baroreflex-responsiveness-is-impaired-in-normotensive-african-american-men/</link>
		<comments>http://ajpheart.podbean.com/2011/11/03/carotid-baroreflex-responsiveness-is-impaired-in-normotensive-african-american-men/#comments</comments>
		<pubDate>Thu, 03 Nov 2011 15:46:17 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/11/03/carotid-baroreflex-responsiveness-is-impaired-in-normotensive-african-american-men/</guid>
		<description><![CDATA[It almost goes without saying that human beings are genetically diverse and that diseases develop differently, and at different rates, across various racial groups in the human population. Case in point: African Americans are predisposed to developing far deadlier forms of hypertension earlier in life than other racial group counterparts. Associate Editor Irving Zucker talks [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;">It almost goes without saying that human beings are genetically diverse and that diseases develop differently, and at different rates, across various racial groups in the human population. Case in point: African Americans are predisposed to developing far deadlier forms of hypertension earlier in life than other racial group counterparts. Associate Editor Irving Zucker talks with lead author David Keller (University of Texas Arlington) and expert Peter Raven (University of North Texas Health Science Center) about the work of Holwerda et al, which studied the possibility of the baroreflex contributing to the development of hypertension in African American males. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"><span style="font-size: small;"><strong>Seth W. Holwerda, Diana Fulton, Wendy L. Eubank, and David M. Keller.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00604.2011"> Carotid Baroreflex Responsiveness is Impaired in Normotensive African American Men.</a><em> Am J Physiol Heart Circ Physiol</em>, October 2011 301:H1639-H1645; published ahead of print August 12, 2011, doi:10.1152/ajpheart.00604.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/11/03/carotid-baroreflex-responsiveness-is-impaired-in-normotensive-african-american-men/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/r7bcrg/AJPHeartPodcast_11_3_11mp3.mp3" length="9572125" type="audio/mpeg"/>
				<itunes:subtitle>It almost goes without saying that human beings are genetically diverse and that diseases develop differently, and at different rates, across various racial groups in ...</itunes:subtitle>
		<itunes:summary>It almost goes without saying that human beings are genetically diverse and that diseases develop differently, and at different rates, across various racial groups in the human population. Case in point: African Americans are predisposed to developing far deadlier forms of hypertension earlier in life than other racial group counterparts. Associate Editor Irving Zucker talks with lead author David Keller (University of Texas Arlington) and expert Peter Raven (University of North Texas Health Science Center) about the work of Holwerda et al, which studied the possibility of the baroreflex contributing to the development of hypertension in African American males. 
Seth W. Holwerda, Diana Fulton, Wendy L. Eubank, and David M. Keller. Carotid Baroreflex Responsiveness is Impaired in Normotensive African American Men. Am J Physiol Heart Circ Physiol, October 2011 301:H1639-H1645; published ahead of print August 12, 2011, doi:10.1152/ajpheart.00604.2011.</itunes:summary>
				<itunes:keywords>blood pressure, heart rate, racial differences,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>09:58</itunes:duration>
	</item>
		<item>
		<title>Shedding of the Glycocalyx and Capillary Hemodynamics</title>
		<link>http://ajpheart.podbean.com/2011/10/20/shedding-of-the-glycocalyx-and-capillary-hemodynamics/</link>
		<comments>http://ajpheart.podbean.com/2011/10/20/shedding-of-the-glycocalyx-and-capillary-hemodynamics/#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:48:15 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/10/20/shedding-of-the-glycocalyx-and-capillary-hemodynamics/</guid>
		<description><![CDATA[We know that the endothelial surface is coated with glycocalyx. But why should we be concerned about the effects of shedding the glycocalyx on microvascular hemodynamics? Editor in Chief William C. Stanley talks with senior author Herbert Lipowsky (Pennsylvania State University) and leading expert Jos A. Spaan (University of Amsterdam) about the unique model presented [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">We know that the endothelial surface is coated with glycocalyx. But why should we be concerned about the effects of shedding the glycocalyx on microvascular hemodynamics? Editor in Chief William C. Stanley talks with senior author Herbert Lipowsky (Pennsylvania State University) and leading expert Jos A. Spaan (University of Amsterdam) about the unique model presented in the article by Lipowsky et al that mimics aspects of acute vascular inflammation and investigates how shedding of the glycocalyx impacts many pathologies including diabetes.</span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Herbert H. Lipowsky, Lujia Gao, and Anne Lescanic.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00803.2011"> Shedding of the Endothelial Glycocalyx in Arterioles, Capillaries and Venules and its Effect on Capillary Hemodynamics During Inflammation.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print September 16, 2011, doi:10.1152/ajpheart.00803.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/10/20/shedding-of-the-glycocalyx-and-capillary-hemodynamics/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/drsv5/AJPHeartPodcast_10_20_11mp3.mp3" length="9504157" type="audio/mpeg"/>
				<itunes:subtitle>We know that the endothelial surface is coated with glycocalyx. But why should we be concerned about the effects of shedding the glycocalyx on microvascular ...</itunes:subtitle>
		<itunes:summary>We know that the endothelial surface is coated with glycocalyx. But why should we be concerned about the effects of shedding the glycocalyx on microvascular hemodynamics? Editor in Chief William C. Stanley talks with senior author Herbert Lipowsky (Pennsylvania State University) and leading expert Jos A. Spaan (University of Amsterdam) about the unique model presented in the article by Lipowsky et al that mimics aspects of acute vascular inflammation and investigates how shedding of the glycocalyx impacts many pathologies including diabetes.
Herbert H. Lipowsky, Lujia Gao, and Anne Lescanic. Shedding of the Endothelial Glycocalyx in Arterioles, Capillaries and Venules and its Effect on Capillary Hemodynamics During Inflammation. Am J Physiol Heart Circ Physiol, published ahead of print September 16, 2011, doi:10.1152/ajpheart.00803.2011.</itunes:summary>
				<itunes:keywords>glycocalyx, glycocalyx thickness, shedding, inflammation, hemodynamics,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>9:54</itunes:duration>
	</item>
		<item>
		<title>DHEA inhibits the Src/STAT3 constitutive activation</title>
		<link>http://ajpheart.podbean.com/2011/10/04/dhea-inhibits-the-srcstat3-constitutive-activation/</link>
		<comments>http://ajpheart.podbean.com/2011/10/04/dhea-inhibits-the-srcstat3-constitutive-activation/#comments</comments>
		<pubDate>Tue, 04 Oct 2011 18:35:35 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/10/04/dhea-inhibits-the-srcstat3-constitutive-activation/</guid>
		<description><![CDATA[Pulmonary hypertension affects millions of patients with increasing prevalence each year, and clinical treatments are still in their infancy. In our latest podcast, Associate Editor Leon de Windt talks with senior author Sebastien Bonnet (Universite Laval) and leading expert Laura Gonzalez Bosc (University of New Mexico) about the article by Paulin et al, which reports [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">Pulmonary hypertension affects millions of patients with increasing prevalence each year, and clinical treatments are still in their infancy. In our latest podcast, Associate Editor Leon de Windt talks with senior author Sebastien Bonnet (Universite Laval) and leading expert Laura Gonzalez Bosc (University of New Mexico) about the article by Paulin et al, which reports the first demonstration of DHEA blocking two major transcription factors—STAT3 and NFAT. Is DHEA, a commercially available natural steroid hormone and antioxidant, the newest entry point for pharmacological intervention and treatment of pulmonary hypertension? Listen in and find out. </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Roxane Paulin, Jolyane Meloche, Maria Helena Jacob, Malik Bisserier, Audrey Courboulin, and Sebastien Bonnet.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00654.2011"> Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.</a><em> Am J Physiol Heart Circ Physiol</em>, published ahead of print September 2, 2011, doi:10.1152/ajpheart.00654.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/10/04/dhea-inhibits-the-srcstat3-constitutive-activation/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/9cbwx/AJPHeartPodcast_10_3_11mp3.mp3" length="9022632" type="audio/mpeg"/>
				<itunes:subtitle>Pulmonary hypertension affects millions of patients with increasing prevalence each year, and clinical treatments are still in their infancy. In our latest podcast, Associate Editor ...</itunes:subtitle>
		<itunes:summary>Pulmonary hypertension affects millions of patients with increasing prevalence each year, and clinical treatments are still in their infancy. In our latest podcast, Associate Editor Leon de Windt talks with senior author Sebastien Bonnet (Universite Laval) and leading expert Laura Gonzalez Bosc (University of New Mexico) about the article by Paulin et al, which reports the first demonstration of DHEA blocking two major transcription factors—STAT3 and NFAT. Is DHEA, a commercially available natural steroid hormone and antioxidant, the newest entry point for pharmacological intervention and treatment of pulmonary hypertension? Listen in and find out. 
Roxane Paulin, Jolyane Meloche, Maria Helena Jacob, Malik Bisserier, Audrey Courboulin, and Sebastien Bonnet. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol, published ahead of print September 2, 2011, doi:10.1152/ajpheart.00654.2011</itunes:summary>
				<itunes:keywords>pulmonary hypertension, dehydroepiandrosterone, vascular remodeling,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>9:23</itunes:duration>
	</item>
		<item>
		<title>Alignment of SR-mitochondrial junctions and contact points</title>
		<link>http://ajpheart.podbean.com/2011/09/28/alignment-of-sr-mitochondrial-junctions-and-contact-points/</link>
		<comments>http://ajpheart.podbean.com/2011/09/28/alignment-of-sr-mitochondrial-junctions-and-contact-points/#comments</comments>
		<pubDate>Wed, 28 Sep 2011 14:55:06 +0000</pubDate>
		<dc:creator>khkeehan</dc:creator>
		
	<category>Uncategorized</category>
		<guid isPermaLink="false">http://ajpheart.podbean.com/2011/09/28/alignment-of-sr-mitochondrial-junctions-and-contact-points/</guid>
		<description><![CDATA[In our latest podcast we explore the connections between the sarcoplasmic reticulum and the mitochondria within calcium regulation during signaling contractile function and regulation of mitochondrial metabolism. Associate Editor Gary Lopaschuk interviews senior author Gyorgy Csordas (Thomas Jefferson University) and leading expert Pal Pacher (National Institutes of Health), seeking to explore a central question in [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;">In our latest podcast we explore the connections between the sarcoplasmic reticulum and the mitochondria within calcium regulation during signaling contractile function and regulation of mitochondrial metabolism. Associate Editor Gary Lopaschuk interviews senior author Gyorgy Csordas (Thomas Jefferson University) and leading expert Pal Pacher (National Institutes of Health), seeking to explore a central question in the work by Garcia-Perez et al—how are the SR and the mitochondria communicating with each other? </span></span></p>
<p class="MsoNoSpacing" style="margin: 0in 0in 0pt;"><span style="font-family: "><span style="font-size: small;"><strong>Cecilia Garcia-Perez, Timothy G. Schneider, Gyorgy Hajnoczky, and Gyorgy Csordas.</strong><a href="http://ajpheart.physiology.org/lookup/doi/10.1152/ajpheart.00397.2011"> Alignment of sarcoplasmic reticulum-mitochondrial junctions with mitochondrial contact points. </a><em>Am J Physiol Heart Circ Physiol</em>, published online ahead of print August 19, 2011, doi:10.1152/ajpheart.00397.2011.</span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://ajpheart.podbean.com/2011/09/28/alignment-of-sr-mitochondrial-junctions-and-contact-points/feed/</wfw:commentRss>
			<enclosure url="http://ajpheart.podbean.com/mf/feed/qi7ve/AJPHeartPodcast_9_27_11mp3.mp3" length="9198881" type="audio/mpeg"/>
				<itunes:subtitle>In our latest podcast we explore the connections between the sarcoplasmic reticulum and the mitochondria within calcium regulation during signaling contractile function and regulation of ...</itunes:subtitle>
		<itunes:summary>In our latest podcast we explore the connections between the sarcoplasmic reticulum and the mitochondria within calcium regulation during signaling contractile function and regulation of mitochondrial metabolism. Associate Editor Gary Lopaschuk interviews senior author Gyorgy Csordas (Thomas Jefferson University) and leading expert Pal Pacher (National Institutes of Health), seeking to explore a central question in the work by Garcia-Perez et al—how are the SR and the mitochondria communicating with each other? 
Cecilia Garcia-Perez, Timothy G. Schneider, Gyorgy Hajnoczky, and Gyorgy Csordas. Alignment of sarcoplasmic reticulum-mitochondrial junctions with mitochondrial contact points. Am J Physiol Heart Circ Physiol, published online ahead of print August 19, 2011, doi:10.1152/ajpheart.00397.2011</itunes:summary>
				<itunes:keywords>sr-mitochondrial tethering, calcium regulation, mfn2,</itunes:keywords>
		<itunes:author>American Physiological Society</itunes:author>
		<itunes:explicit>No</itunes:explicit>
		<itunes:block>No</itunes:block>
		<itunes:duration>9:34</itunes:duration>
	</item>
	</channel>
</rss>

